A
Allan C. Halpern
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 314
Citations - 20076
Allan C. Halpern is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Skin cancer & Melanoma. The author has an hindex of 69, co-authored 290 publications receiving 17043 citations. Previous affiliations of Allan C. Halpern include American Academy of Dermatology & University of Pennsylvania.
Papers
More filters
Proceedings ArticleDOI
Skin lesion analysis toward melanoma detection: A challenge at the 2017 International symposium on biomedical imaging (ISBI), hosted by the international skin imaging collaboration (ISIC)
Noel C. F. Codella,David A. Gutman,M. Emre Celebi,Brian Helba,Michael A. Marchetti,Stephen W. Dusza,Aadi Kalloo,Konstantinos Liopyris,Nabin K. Mishra,Harald Kittler,Allan C. Halpern +10 more
TL;DR: The most recent edition of the dermoscopic image analysis benchmark challenge as discussed by the authors was organized to support research and development of algorithms for automated diagnosis of melanoma, the most lethal skin cancer.
Journal ArticleDOI
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Wallace H. Clark,David E. Elder,DuPont Guerry,Leonard E. Braitman,Bruce J. Trock,Delray Schultz,Marie Synnestvedt,Allan C. Halpern +7 more
TL;DR: A prognostic model for primary, clinical stage I cutaneous melanoma was developed using the lesional steps in tumor progression and multivariable logistic regression to develop a model that is 89% accurate in predicting survival.
Journal ArticleDOI
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet
Giuseppe Argenziano,H. Peter Soyer,Sergio Chimenti,Renato Talamini,Rosamaria Corona,Francesco Sera,Michael Binder,Lorenzo Cerroni,Gaetano De Rosa,Gerardo Ferrara,Rainer Hofmann-Wellenhof,Michael Landthaler,Scott W. Menzies,Hubert Pehamberger,Domenico Piccolo,Harold S. Rabinovitz,R. Schiffner,Stefania Staibano,Wilhelm Stolz,Igor Bartenjev,Andreas Blum,Ralph P. Braun,Horacio Cabo,Paolo Carli,Vincenzo De Giorgi,Matthew G. Fleming,James M. Grichnik,Caron M. Grin,Allan C. Halpern,Robert H. Johr,Brian Katz,Robert O. Kenet,Harald Kittler,Jürgen Kreusch,Josep Malvehy,G. Mazzocchetti,Margaret Oliviero,Fezal Ozdemir,Ketty Peris,Roberto Perotti,Ana Perusquia,Maria Antonietta Pizzichetta,Susana Puig,Babar Rao,Pietro Rubegni,Toshiaki Saida,Massimiliano Scalvenzi,Stefania Seidenari,Ignazio Stanganelli,Masaru Tanaka,Karin Westerhoff,Ingrid H. Wolf,Otto Braun-Falco,Helmut Kerl,Takeji Nishikawa,Klaus Wolff,Alfred W. Kopf +56 more
TL;DR: The virtual Consensus Net Meeting on Dermoscopy represents a valid tool for better standardization of the dermoscopic terminology and, moreover, opens up a new territory for diagnosing and managing pigmented skin lesions.
Posted Content
Skin Lesion Analysis Toward Melanoma Detection 2018: A Challenge Hosted by the International Skin Imaging Collaboration (ISIC)
Noel C. F. Codella,Veronica Rotemberg,Philipp Tschandl,M. Emre Celebi,Stephen W. Dusza,David A. Gutman,Brian Helba,Aadi Kalloo,Konstantinos Liopyris,Michael A. Marchetti,Harald Kittler,Allan C. Halpern +11 more
TL;DR: This work summarizes the results of the largest skin image analysis challenge in the world, hosted by the International Skin Imaging Collaboration (ISIC), a global partnership that has organized the world's largest public repository of dermoscopic images of skin.
Journal ArticleDOI
Guidelines of care for the management of primary cutaneous melanoma
Christopher K. Bichakjian,Allan C. Halpern,Timothy M. Johnson,Antoinette F. Hood,James M. Grichnik,Susan M. Swetter,Susan M. Swetter,Hensin Tsao,Victoria Holloway Barbosa,Tsu Yi Chuang,Madeleine Duvic,Vincent C. Ho,Arthur J. Sober,Karl R. Beutner,Reva Bhushan,Wendy Smith Begolka +15 more
TL;DR: The value and limitations of sentinel lymph node biopsy and recommendations for its use in patients with primary cutaneous melanoma are discussed and the use of laboratory and imaging tests in the initial workup of patients with newly diagnosed melanoma is offered.